BAUM CAROL A 4
4 · Orexigen Therapeutics, Inc. · Filed Apr 27, 2009
Insider Transaction Report
Form 4
BAUM CAROL A
VP, Commercialization
Transactions
- Award
Stock option (right to buy)
2009-04-23+41,913→ 41,913 totalExercise: $2.13Exp: 2019-04-22→ Common Stock (41,913 underlying)
Footnotes (2)
- [F1]1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting person's service as an employee, director or consultant following 4/23/2009, so that all of the shares of the stock subject to the option shall be vested on 4/23/2013, subject to the reporting person's continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]Not applicable.